International
Novartis Defeat Revives Debate Over Patents' Life Span
When India's Supreme Court ruled that Novartis AG's cancer drug Gleevec was not sufficiently innovative to merit a patent, the decision revolved around a practice the pharmaceutical industry refers to as "life-cycle management" and which public health advocates call "evergreening."
Cyprus and the Compliance Risks of Offshore Accounts
The recent financial chaos in Cyprus underscores the exotic world of offshore accounts and holding companies, tax havens, and the risk of money laundering.
Acing Anticorruption Due Diligence in M&A Deals
One thing companies in an M&A state of mind should know about anticorruption due diligence is this: government enforcement agencies really, really like it.
Using BITs to Protect a Company's Foreign Assets
When foreign investments go south, companies may have the ability to seek relief under bilateral investment treaties, agreements between two countries that establish terms and conditions for businesses to invest their capital in each country, and typically offer a number of guaranteed protections.
3 Compliance Lessons from the Wal-Mart Bribery Scandal
Documents from the investigation into the Wal-Mart Stores Inc. Mexico bribery scandal are reminders to in-house counsel that they must keep close tabs on their company's foreign subsidiaries.
Enforcing Foreign and Nondomestic Arbitration Awards
The international scope of energy transactions commonly leads parties to incorporate arbitration as their method of dispute resolution. When the arbitration concludes, the award does not always lead to final resolution.
Why Investors Should Mourn for Hugo Chavez
The late Venezuelan president posed as the mad dog of the Americas, but the record shows he was a man you could do business with.
Lady Gaga Promoter Sues to Collect Terrorism Insurance
Concert promoter Live Nation has sued syndicates of insurer Lloyd's of London for their "despicable conduct" in refusing to cover losses stemming from a performance by Lady Gaga in Indonesia that was canceled last year after the pop star received threats from an Islamic terrorist group.
India Patent Ruling on Cancer Drug a Blow to Bayer AG
India's patent appeals board ruled that a domestic generic drug maker could continue to make and sell a low-priced copy of Nexavar, a cancer medication patented by Bayer AG.
The Dirty Business of Green Tech
Clean tech is new: solar, wind, biofuels, water purification. And yet the industry runs the very ordinary risk of getting bogged down in the oldest business challenge of all: corruption.
Corporate Counsel Membership Program
Receive exclusive offers and discounts today!
- Digital editions of Corporate Counsel Magazine
- Corporate Counsel eNewsletters
- Discounts on books, events, online CLE and research
